English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCaplinpointlaboratories

    Jump to
    • Accumulate Caplin Point Laboratories; target of Rs 1675: Asit C Mehta

      Accumulate Caplin Point Laboratories; target of Rs 1675: Asit C Mehta

      Asit C Mehta recommended accumulate rating on Caplin Point Laboratories with a target price of Rs 1675 in its research report dated April 25 2024.

    • Buy Caplin Point Laboratories; target of Rs 955: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 955: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories recommended buy rating on the stock with a target price of Rs 955 in its research report dated November 13, 2022.

    • Buy Caplin Point Laboratories target of Rs 1000: ICICI Direct

      Buy Caplin Point Laboratories target of Rs 1000: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 06, 2022.

    • Buy Caplin Point Laboratories; target of Rs 895: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 895: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 895 in its research report dated May 13, 2022.

    • Accumulate Caplin Point; target of Rs 896: Hem Securities

      Accumulate Caplin Point; target of Rs 896: Hem Securities

      Hem Securities recommended Accumulate rating on Caplin Point with a target price of Rs 896 in its research report dated December 26, 2021.

    • Buy Caplin Point Laboratories; target of Rs 1080: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 1080: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated November 03, 2021.

    • Buy Caplin Point Laboratories; target of Rs 1135: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 1135: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated August 07, 2021.

    • Buy Caplin Point Laboratories; target of Rs 605: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 605: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 605 in its research report dated February 05, 2021.

    • Buy Caplin Point Laboratories; target of Rs 605: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 605: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 605 in its research report dated November 06, 2020.

    • Buy Caplin Point Laboratories; target of Rs 670: ICICI Direct

      Buy Caplin Point Laboratories; target of Rs 670: ICICI Direct

      ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 12, 2020.

    • Buy Caplin Point Labs; target Rs 54: Firstcall Research

      Buy Caplin Point Labs; target Rs 54: Firstcall Research

      Brokerage house Firstcall Research is bullish on Caplin Point Laboratories and has recommended buy rating on the stock with a target price of Rs 54 in its July 01, 2013 research report.

    • Buy Caplin Point Labs; target Rs 76: Firstcall Research

      Buy Caplin Point Labs; target Rs 76: Firstcall Research

      Firstcall Research is bullish on Caplin Point Laboratories and has recommended buy rating on the stock with a target price of Rs 76 in its March 15, 2013 research report.

    • Buy Caplin Point Labs; target Rs 100: Firstcall Research

      Buy Caplin Point Labs; target Rs 100: Firstcall Research

      Firstcall Research is bullish on Caplin Point Laboratories and has recommended buy rating on the stock with a target price of Rs 100 in its January 09, 2013 research report.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347